Clinical Trial Update: Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans [Phase 1]

View source ↗

Summary

Yale University is conducting a fixed-order, open-label, dose-escalation Phase 1 trial of dimethyltryptamine (DMT). The study targets individuals with major dep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• dimethyltryptamine (dimethyltryptamine)

Snippet

Sponsor: Yale University | Conditions: Major Depressive Disorder, Depression | Phase 1 | Status: ACTIVE_NOT_RECRUITING